Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 3'-untranslated region (3'-UTR) of the AMPKα mRNA is a critical regulatory segment that controls the expression of the catalytic alpha subunit of AMP-activated protein kinase (AMPK). AMPK serves as a master regulator of cellular energy homeostasis, activating catabolic pathways to generate ATP while inhibiting anabolic processes during energy stress (Hardie et al., 2012, Genes & Development). The 3'-UTR contains specific binding sites for microRNAs, such as miR-33 and miR-451, which post-transcriptionally repress AMPK expression by inducing mRNA degradation or inhibiting translation (Davalos et al., 2011, Nature; Godlewski et al., 2010, Cancer Research). In metabolic diseases like obesity and type 2 diabetes, the overexpression of certain microRNAs can lead to pathologically low levels of AMPK, exacerbating insulin resistance and lipid accumulation. Consequently, the AMPKα mRNA 3'-UTR is an emerging therapeutic target for RNA-based interventions, including antisense oligonucleotides and microRNA modulators, designed to restore AMPK activity. Beyond metabolism, this regulatory region is also studied in oncology, where AMPK acts as a metabolic tumor suppressor that can be silenced by microRNAs in the tumor microenvironment.
Modulation of AMPK protein expression through the regulation of mRNA stability or translation efficiency, often by blocking or mimicking microRNA binding to the 3'-UTR to either increase or decrease AMPK levels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-AMP-activated protein kinase catalytic subunit alpha mRNA 3'-untranslated region (AMPKα mRNA 3'-UTR).